Inclusion body myositis: new insights into pathogenesis and therapeutic perspectives.
PURPOSE OF REVIEW Inclusion body myositis (IBM) is the most common acquired myopathy in individuals over 50 years of age and remains refractory to conventional immunosuppressive therapies. This review summarizes recent advances in the understanding of IBM pathogenesis and highlights emerging therapeutic strategies. R...